The Effect of Shotblocker on Pain Violence and Injection Satisfaction
Condition: Pain
Study type: Interventional

Summary: 
      This study was conducted to determine the effect of Shotblocker on pain level and injection
      satisfaction in SC injection administrations. The study was completed with 120 patients who
      were hospitalized in orthopedic clinic of a training and research hospital to receive
      treatment and met the inclusion criteria of the study. In addition to Standard practices for
      the clinic, the individuals in the intervention group received LMWH treatments via
      Shotblocker three times as once per day by administering SC from theside of the patients'
      upper armand thetreatment made with there ady injector of LMWH was ended within 20 seconds
      and the light pressure was applied to the injection site for 30 seconds. .
    

Detailed description: 
      I Intervention Group: Before starting the application, the researcher informed the patients
      in the intervention group about the purpose of the study and their verbal and written
      informed consents were obtained.

      The individuals to be included in the intervention and control groups were randomized by a
      faculty member at the Biostatistics Department of a university in the computer environment.
      The application was initiated by including the patients meeting the inclusion criteria on
      04.12.2017. During the study, no intervention was made on the routine treatments of the
      patients in the intervention and control groups. Before the application, patient information
      form of each patient was filled using face-to-face interview technique.

      Since the patients included in the study were discharged early (mean hospitalization duration
      was 3 days), the first, third and fifth SC heparin injection (0.6 ml) administrations were
      performed by the researcher for three days. The application was made to the arm area due to
      the fact that Shotblocker was difficult to place in the abdominal area, and the outer side of
      the arm was preferred for subcutaneous injection administrations in the clinic where the
      study was conducted. Shotblocker was placed on the injection site determined on the outer
      side of the upper arm of the patient and the injection was administered by gently pressing
      the tool with the fingertips during the injection. Shotblocker was removed after removal of
      the injector. Injections were completed in 20 seconds and the injection site was supported
      with cotton for 30 seconds. In the first minute after each SC injection application, the
      patients were asked about the pain level felt during the injection and the injection
      satisfaction status.

      Control Group: Verbal and written informed consents of the patients included in the control
      group were obtained after they were informed by the researcher. Before the application,
      questions in patient information form were asked to each patient and how to use the VAS pain
      and injection satisfaction scale was explained. During injection, SC Clexan (0.6 ml) was
      injected on the site without using Shotblocker. Injections were completed in 20 seconds and
      the site was supported for 30 seconds. In the first minute after each SC injection
      administration, the patients were asked about pain level felt during the injection and
      injection satisfaction status.

      In this study, the researcher administered all SC injections by throughout the study by
      considering the reliability of the study results.
    

Intervention name(s): Shotblocker
Intervention type(s): Device
Intervention description(s): Shotblocker is a small plastic tool that can be used in all age groups in reducing pain due to injection, is non-medicinal, non-invasive, easy to use, and inexpensive and does not require material preparation
Allocation: Randomized
Intervention model: Single Group Assignment
Intervention model description: The study was conducted in a randomized controlled study design in order to determine the effect of Shotblocker on pain and injection satisfaction in patients who were using DMAH and received subcutaneous injection after arthroplasty surgery in orthopedics training clinic.
Masking: Single (Participant)
Primary purpose: Supportive Care
Keywords: Subcutaneous injection; Pain; ShotBlocker.